ArticleAnnals of translational medicine2024

Erratum to ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway.

Editorial OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.